Skip to main content
. 2015 May 29;6(21):18631–18640. doi: 10.18632/oncotarget.4072

Figure 1. Expression of miR-26a in the serum of CCA patients.

Figure 1

A. The levels of serum miR-26a in normal controls and CCA patients. B. The level of serum miR-26a in different TNM stages of CCA patients. Two-tailed Student's t test was used to analyze the significant differences. *P < 0.05.